STEALTH BIOTHERAPEUTICS
Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial dysfunction. Mitochondria, found in nearly every cell in the body, are the body's main source of energy production and are critical for normal organ function. The company was founded in 2007 and is based in Newton, Massachusetts, United States.
STEALTH BIOTHERAPEUTICS
Industry:
Biopharma Biotechnology Pharmaceutical Therapeutics
Founded:
2007-01-01
Address:
Newton, Massachusetts, United States
Country:
United States
Website Url:
http://www.stealthbt.com
Total Employee:
51+
Status:
Active
Contact:
(617)600-6888
Email Addresses:
[email protected]
Total Funding:
191.4 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving SPF Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Analytics LetsEncrypt SSL By Default
Similar Organizations
Aclaris Therapeutics
Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Arcutis Biotherapeutics
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
FibroGen
FibroGen, a research-based biotech firm, uses its expertise CTGF and HIF biology to discover, develop, and commercialize novel therapeutics.
Imvax
Imvax is a biotechnology company focused on the development of novel patient-specific vaccines and immunotherapy strategies.
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
KSQ Therapeutics
KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development.
SwanBio Therapeutics
SwanBio Therapeutics is a gene therapy company focused on the development and commercialisation of genetically defined therapies.
TreeFrog Therapeutics
TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Horizon Technology Finance
Horizon Technology Finance investment in Post-IPO Debt - Stealth BioTherapeutics
Morningside Venture Investments
Morningside Venture Investments investment in Post-IPO Equity - Stealth BioTherapeutics
Morningside Venture Investments
Morningside Venture Investments investment in Post-IPO Equity - Stealth BioTherapeutics
Kingdon Capital
Kingdon Capital investment in Convertible Note - Stealth BioTherapeutics
Pivotal bioVenture Partners
Pivotal bioVenture Partners investment in Convertible Note - Stealth BioTherapeutics
Atlantis Investment Management
Atlantis Investment Management investment in Convertible Note - Stealth BioTherapeutics
BVCF
BVCF investment in Convertible Note - Stealth BioTherapeutics
CMBC Capital Holdings
CMBC Capital Holdings investment in Convertible Note - Stealth BioTherapeutics
Sagamore Investments
Sagamore Investments investment in Convertible Note - Stealth BioTherapeutics
Ocean Equity Partners
Ocean Equity Partners investment in Convertible Note - Stealth BioTherapeutics
Official Site Inspections
http://www.stealthbt.com Semrush global rank: 7.52 M Semrush visits lastest month: 744
- Host name: 89.75.83.34.bc.googleusercontent.com
- IP address: 34.83.75.89
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Stealth BioTherapeutics"
Our Company - StealthBiotherapeutics
Mike’s experience includes working at both small and large companies within diverse industries. He joined Ironwood Pharmaceuticals in 2007 as Head of Human Resources where he built and led the HR function during a period of …See details»
Stealth BioTherapeutics - Crunchbase Company Profile …
Contact Email [email protected] Phone Number (617)600-6888 Stealth is a clinical-stage biotechnology company focused on the discovery, development and commercialization of novel therapies for diseases involving mitochondrial …See details»
Overview, News & Similar companies - ZoomInfo.com
Stealth BioTherapeutics contact info: Phone number: (617) 600-6888 Website: www.stealthbt.com What does Stealth BioTherapeutics do? Stealth BioTherapeutics is a clinical-stage …See details»
MitoWorld
We are an innovative biopharmaceutical company developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related …See details»
Stealth BioTherapeutics - LinkedIn
Stealth exclusively uses @stealthbt.com e-mail addresses for recruitment purposes and does not conduct interviews via social media or other third-party sites. Please report any suspicious ...See details»
Home - Stealth BioTherapeutics
As listed on ClinicalTrials.gov, Stealth BioTherapeutics Inc. is conducting two studies in primary mitochondrial myopathy (PMM):. RePOWER: A prospective, non-interventional study of patients with PMM. RePOWER is fully enrolled.; …See details»
Stealth BioTherapeutics Corp Announces Completion of Merger
Nov 16, 2022 --Stealth BioTherapeutics Corp, a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases …See details»
Stealth BioTherapeutics CEO Reenie McCarthy …
NEEDHAM, MA - June 14, 2023 -- Stealth BioTherapeutics Inc. (the "Company" or "Stealth BioTherapeutics"), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for …See details»
Working at Stealth BioTherapeutics - Zippia
Mar 14, 2024 www.stealthbt.com. Organization Type. Public. Social Media. Stealth BioTherapeutics is an innovative biopharmaceutical company developing therapies to treat …See details»
Reenie McCarthy - Biotechnology Innovation Organization - LinkedIn
I’m leading an incredibly dedicated group of professionals at Stealth BioTherapeutics… · Experience: Biotechnology Innovation Organization · Location: Newton Centre · 500+ …See details»
Stealth BioTherapeutics Presents Data of Novel Compound, SBT …
Mar 19, 2024 SBT-589 showed mitochondrial protection across models of Friedreich’s ataxiaSBT-589 displayed cardioprotective effects in aggressive mouse model of FA …See details»
Stealth BioTherapetuics Receives Nasdaq Notifications Regarding …
Jan 7, 2022 Investor RelationsStern Investor Relations Janhavi Mohite, [email protected]. View original content to download multimedia:https: ...See details»
Stealth BioTherapeutics Provides Update on Phase 3 Trial of ...
BOSTON, Dec. 20, 2019 /PRNewswire/ -- Stealth BioTherapeutics (NASDAQ: MITO), a clinical-stage biotechnology company focused on the discovery, development and commercialization …See details»
Privacy Policy | Stealth BioTherapeutics
Where we hold personal information about you with your consent or for the performance of a contract with you, you also have the right to ask us to provide you with the personal …See details»
Our Company | StealthBiotherapeutics
We are an innovative biopharmaceutical company developing therapies to treat the mitochondrial dysfunction associated with genetic mitochondrial diseases and many common age-related …See details»
Stealth BioTherapeutics enrolls first patient in global Phase 3 ...
Jun 6, 2024 Stealth BioTherapeutics Inc announced it has enrolled and dosed its first patient in the ReNEW trial (NCT06373731) as part of its Phase 3 clinical program for elamipretide in …See details»
Stealth BioTherapeutics presents preclinical data on …
Sep 21, 2024 Stealth BioTherapeutics Inc. presented new bevemipretide (SBT-272) preclinical data from a study demonstrating topical ocular delivery to the retina with protective effects …See details»
Elamipretide Clinical Studies and Trials | Stealth BioTherapeutics
Stealth’s lead investigational product candidate, elamipretide, is a peptide compound that readily penetrates cell membranes, and targets the inner mitochondrial membrane where it binds …See details»
Educational Grant Funding Application - stealthbt.com
Organization Name: Address: City: State: Country:Zip Code: Phone: Fax: Contact Name: Email: Email completed forms to: [email protected] Please attach a W-9, W-8 or W-8BEN-E …See details»